Atlas Trials

Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)

Clinical trial NCT01205152 · COMPLETED

Trial details

NCT number
NCT01205152
Sponsor
Alexion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypophosphatasia
Start date
2009-04-01
Primary completion
2016-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.